AROTECH
250 West 57th Street, Suite 310, New York, NY 10107               Corporate News
Tel: (212) 258-3222o Fax: (212) 258-3281
WWW.AROTECH.COM

FOR IMMEDIATE RELEASE

                   AROTECH CORPORATION ANNOUNCES $6.6 MILLION
                             DIRECT EQUITY PLACEMENT

   Company also receives $16.5 million from exercises of outstanding warrants

      NEW  YORK,  NY - JULY 15,  2004 -  Arotech  Corporation  (NasdaqNM:  ARTX)
announced  today that it has entered  into a definitive  agreement  with several
institutional  investors for the purchase of an aggregate of 4,258,065 shares of
its  common  stock  at  $1.55  per  share  off  of  Arotech's   effective  shelf
registration  statement.  Gross proceeds to Arotech will be  approximately  $6.6
million.   The  proceeds  of  the  offering  will  be  used  primarily  for  the
acquisition,  announced today in a separate press release,  of Armour of America
Incorporated.

      The Company  also  announced  that it had  previously  received a total of
$16.5 million upon exercise of a total of 8,814,235 of its outstanding warrants.
As part of the consideration for their exercise,  these warrant holders received
an equal number of new warrants at an exercise  price to be determined  based on
90% of the variable  weighted average of the price of the Company's common stock
on the Nasdaq  Stock  Market over the next three days,  but not more than $1.88.
The new warrants  that were issued and the shares  underlying  the warrants have
not been registered under the Securities Act of 1933, as amended, and may not be
offered or sold in the United States absent  registration  under the  Securities
Act  and  applicable  state  securities  or an  applicable  exemption  from  the
registration requirements of such act. Arotech has agreed to file a registration
statement  covering the shares of common stock issuable upon exercise of the new
warrants.

      If the acquisition of Armour of America is for any reason not consummated,
the  proceeds  will be used for general  corporate  purposes,  which may include
acquisitions  or investments in businesses,  products or  technologies  that are
complementary  to the Company's own, funding  research,  development and product
manufacturing,  increasing the Company's working capital, reducing indebtedness,
and capital expenditures.

      This press release shall not constitute an offer to sell or a solicitation
of an offer to buy, nor shall there be any sale of these securities in any state
in  which  such  offer,   solicitation  or  sale  would  be  unlawful  prior  to
registration or qualification under the securities laws of any such state.

ABOUT AROTECH CORPORATION

      Arotech Corporation provides quality defense and security products for the
military,  law enforcement and homeland  security  markets,  including  advanced
zinc-air   and  lithium   batteries   and   chargers,   multimedia   interactive
simulators/trainers and lightweight vehicle armoring.



      The Battery and Power  Systems  Division  includes  Electric  Fuel Battery
Corporation and Epsilor  Electronic  Industries.  The  Simulation,  Training and
Consulting Division includes IES Interactive Training and FAAC Incorporated. The
Armored Vehicle Division  includes MDT Armor Corp and MDT Protective  Industries
Ltd.

      Arotech is incorporated in Delaware,  with corporate  offices in New York,
and research,  development  and production  subsidiaries  in Alabama,  Colorado,
Michigan and Israel.

COMPANY CONTACT:
Jonathan Whartman, Senior VP, Communications
1-866-325-6963, whartman@arotech.com
NY Office 1-212-258-3222

Except for the historical information herein, the matters discussed in this news
release include forward-looking statements, as defined in the Private Securities
Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance
on these  forward-looking  statements,  as they are subject to various risks and
uncertainties that may cause actual results to vary  significantly.  These risks
and  uncertainties  include,  but are not limited to, risks relating to: product
and  technology  development;  the  uncertainty  of  the  market  for  Arotech's
products;  changing economic conditions;  delay, cancellation or non-renewal, in
whole or in part,  of  contracts or of purchase  orders;  and other risk factors
detailed in Arotech's most recent Annual Report on Form 10-K for the fiscal year
ended  December  31, 2003 and other  filings  with the  Securities  and Exchange
Commission.  Arotech  assumes no  obligation to update the  information  in this
release.   Reference  to  the  Company's   website  above  does  not  constitute
incorporation of any of the information thereon into this press release.

                                     #####